Logo

Seegene Receives Canadian Approval for Allplex Respiratory MDx Test

Mar 02, 2015 | staff reporter

NEW YORK (GenomeWeb) – Seegene today announced that Health Canada has approved its multiplexed Allplex Respiratory Panel 5 assay.

The real-time PCR-based molecular diagnostic test identifies influenza virus A subtypes H1 and H3, influenza B, and human respiratory syncytial viruses A and B.

Seoul, South Korea-based Seegene now offers ten infectious disease tests in Canada, the firm said in a statement.

In February the firm received US Food and Drug Administration approval for its test for herpes simplex viruses 1 and 2, its first foray into the American market. 

Seegene said that it is pursuing submissions of other Allplex tests for the European, Canadian, and American markets.

Filed under

Molecular Diagnostics
Regulatory News & FDA Approvals
Infectious Disease
respiratory infection
Health Canada
Seegene
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.